It is a pharma private limited company based in Secunderabad, Telangana, India, established in 1984.
1984 | Secunderabad, Telangana, India | ActiveGilman Laboratories Pvt Ltd, a active private limited company, was established on 05 December 1984 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231TG1984PTC005163. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.21 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Purushotham Lakshman Shanbhag (Director), Sunil Sheshagiri Kamath (Director), Suresh Voderbettu Kamath (Additional Director). Past directors included Sarvottam Voderabettu Kamath. It holds ₹4.54 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 16D, Aswini Nagar Colonywest Maredmally Secunderabad, Secunderabad, Telangana, 500009.
U24231TG1984PTC005163
005163
05 December 1984
₹1.50 M
₹1.21 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Gilman Laboratories Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Purushotham Lakshman Shanbhag | Director | 03 Feb 1998 | Current |
| Sunil Sheshagiri Kamath | Director | 03 Feb 1998 | Current |
| Suresh Voderbettu Kamath | Additional Director | 04 Apr 2016 | Current |
| Vasanth Venkatray Kamath | Director | 03 Feb 1998 | Current |
| Ahmed Najaf Syed | Managing Director | 03 Feb 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Apr 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gilman Laboratories Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 3.34% increase. The company also saw a slight improvement in profitability, with a 2.61% increase in profit. The company's net worth dipped by a decrease of 9.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gilman Laboratories had a promoter holding of 76.78% and a public holding of 23.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,540,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 1999 | Canara Bank | ₹0.70 M | Open |
| 20 Dec 1995 | Canara Bank | ₹0.20 M | Open |
| 20 Dec 1995 | Canara Bank | ₹1.70 M | Open |
| 19 May 1994 | Canara Bank | ₹0.17 M | Open |
| 18 May 1994 | Canara Bank | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Gilman Laboratories has a workforce of 10 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gilman Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gilman Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gilman Laboratories Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Gilman Laboratories Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Suresh Voderbettu Kamath was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
A charge with Canara Bank of Rs. 1.70 M registered on 20 Dec 1995 with Charge ID 90129496 was modified on 09 Dec 2009. was recorded as a recent event.
The activity A charge with Canara Bank amounted to Rs. 0.70 M with Charge ID 90126094 was registered on 05 May 1999. was completed.
Purushotham Lakshman Shanbhag was appointed as a Director was appointed as a Director on 03 Feb 1998 & has been associated with this company since 27 years 9 months . was recorded as a recent event.
The CIN of Gilman Laboratories Pvt Ltd is U24231TG1984PTC005163.
Gilman Laboratories Pvt Ltd is headquartered at 16D, Aswini Nagar Colonywest Maredmally Secunderabad, Secunderabad, Telangana, 500009.
Gilman Laboratories Pvt Ltd was incorporated on 05 December 1984.
The current directors of Gilman Laboratories Pvt Ltd are
The primary industry of Gilman Laboratories Pvt Ltd is Trade.
Gilman Laboratories Pvt Ltd is unlisted.
The authorized capital of Gilman Laboratories Pvt Ltd is ₹1.50 M, and the paid-up capital is ₹1.21 M.
The compliance status of Gilman Laboratories Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX